359 related articles for article (PubMed ID: 1355364)
1. The amino-terminal peptide of HIV-1 glycoprotein 41 interacts with human erythrocyte membranes: peptide conformation, orientation and aggregation.
Gordon LM; Curtain CC; Zhong YC; Kirkpatrick A; Mobley PW; Waring AJ
Biochim Biophys Acta; 1992 Aug; 1139(4):257-74. PubMed ID: 1355364
[TBL] [Abstract][Full Text] [Related]
2. The amino-terminal peptide of HIV-1 gp41 interacts with human serum albumin.
Gordon LM; Curtain CC; McCloyn V; Kirkpatrick A; Mobley PW; Waring AJ
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1145-56. PubMed ID: 8312056
[TBL] [Abstract][Full Text] [Related]
3. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in membrane environments using (13)C-enhanced Fourier transform infrared spectroscopy.
Gordon LM; Mobley PW; Pilpa R; Sherman MA; Waring AJ
Biochim Biophys Acta; 2002 Feb; 1559(2):96-120. PubMed ID: 11853678
[TBL] [Abstract][Full Text] [Related]
4. Antivirals that target the amino-terminal domain of HIV type 1 glycoprotein 41.
Gordon LM; Waring AJ; Curtain CC; Kirkpatrick A; Leung C; Faull K; Mobley PW
AIDS Res Hum Retroviruses; 1995 Jun; 11(6):677-86. PubMed ID: 7576927
[TBL] [Abstract][Full Text] [Related]
5. Membrane-perturbing domains of HIV type 1 glycoprotein 41.
Mobley PW; Pilpa R; Brown C; Waring AJ; Gordon LM
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):311-27. PubMed ID: 11242518
[TBL] [Abstract][Full Text] [Related]
6. Membrane interactions of the synthetic N-terminal peptide of HIV-1 gp41 and its structural analogs.
Mobley PW; Waring AJ; Sherman MA; Gordon LM
Biochim Biophys Acta; 1999 Apr; 1418(1):1-18. PubMed ID: 10209206
[TBL] [Abstract][Full Text] [Related]
7. The amino-terminal peptide of HIV-1 glycoprotein 41 lyses human erythrocytes and CD4+ lymphocytes.
Mobley PW; Curtain CC; Kirkpatrick A; Rostamkhani M; Waring AJ; Gordon LM
Biochim Biophys Acta; 1992 Aug; 1139(4):251-6. PubMed ID: 1355363
[TBL] [Abstract][Full Text] [Related]
8. Conformational mapping of the N-terminal peptide of HIV-1 gp41 in lipid detergent and aqueous environments using 13C-enhanced Fourier transform infrared spectroscopy.
Gordon LM; Mobley PW; Lee W; Eskandari S; Kaznessis YN; Sherman MA; Waring AJ
Protein Sci; 2004 Apr; 13(4):1012-30. PubMed ID: 15044732
[TBL] [Abstract][Full Text] [Related]
9. Solid-state NMR spectroscopy of the HIV gp41 membrane fusion protein supports intermolecular antiparallel β sheet fusion peptide structure in the final six-helix bundle state.
Sackett K; Nethercott MJ; Zheng Z; Weliky DP
J Mol Biol; 2014 Mar; 426(5):1077-94. PubMed ID: 24246500
[TBL] [Abstract][Full Text] [Related]
10. Conformation and molecular topography of the N-terminal segment of surfactant protein B in structure-promoting environments.
Gordon LM; Horvath S; Longo ML; Zasadzinski JA; Taeusch HW; Faull K; Leung C; Waring AJ
Protein Sci; 1996 Aug; 5(8):1662-75. PubMed ID: 8844855
[TBL] [Abstract][Full Text] [Related]
11. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation.
Rabenstein M; Shin YK
Biochemistry; 1995 Oct; 34(41):13390-7. PubMed ID: 7577925
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional properties of peptides based on the N-terminus of HIV-1 gp41 and the C-terminus of the amyloid-beta protein.
Gordon LM; Nisthal A; Lee AB; Eskandari S; Ruchala P; Jung CL; Waring AJ; Mobley PW
Biochim Biophys Acta; 2008 Oct; 1778(10):2127-37. PubMed ID: 18515070
[TBL] [Abstract][Full Text] [Related]
13. Solid-state nuclear magnetic resonance measurements of HIV fusion peptide 13CO to lipid 31P proximities support similar partially inserted membrane locations of the α helical and β sheet peptide structures.
Gabrys CM; Qiang W; Sun Y; Xie L; Schmick SD; Weliky DP
J Phys Chem A; 2013 Oct; 117(39):9848-59. PubMed ID: 23418890
[TBL] [Abstract][Full Text] [Related]
14. Membrane perturbing actions of HIV type 1 glycoprotein 41 domains are inhibited by helical C-peptides.
Mobley PW; Barry JA; Waring AJ; Sherman MA; Gordon LM
AIDS Res Hum Retroviruses; 2007 Feb; 23(2):224-42. PubMed ID: 17331029
[TBL] [Abstract][Full Text] [Related]
15. Effect of the conformation of a peptide from gp41 on binding and domain formation in model membranes.
Koenig BW; Bergelson LD; Gawrisch K; Ward J; Ferretti JA
Mol Membr Biol; 1995; 12(1):77-82. PubMed ID: 7767387
[TBL] [Abstract][Full Text] [Related]
16. Global topology & stability and local structure & dynamics in a synthetic spin-labeled four-helix bundle protein.
Gibney BR; Johansson JS; Rabanal F; Skalicky JJ; Wand AJ; Dutton PL
Biochemistry; 1997 Mar; 36(10):2798-806. PubMed ID: 9062107
[TBL] [Abstract][Full Text] [Related]
17. Conformational partitioning of the fusion peptide of HIV-1 gp41 and its structural analogs in bilayer membranes.
Maddox MW; Longo ML
Biophys J; 2002 Dec; 83(6):3088-96. PubMed ID: 12496080
[TBL] [Abstract][Full Text] [Related]
18. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
Lev N; Shai Y
J Mol Biol; 2007 Nov; 374(1):220-30. PubMed ID: 17919659
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of membrane-associated fusion peptide secondary structure and lipid mixing function of HIV gp41 constructs that model the early pre-hairpin intermediate and final hairpin conformations.
Sackett K; Nethercott MJ; Epand RF; Epand RM; Kindra DR; Shai Y; Weliky DP
J Mol Biol; 2010 Mar; 397(1):301-15. PubMed ID: 20080102
[TBL] [Abstract][Full Text] [Related]
20. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.
Pritsker M; Jones P; Blumenthal R; Shai Y
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7287-92. PubMed ID: 9636141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
